Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

“the word is out there already for potential suitors that a major indication is doable and could be another gold mine.”

Jess care to share more on this? This would be news if true.

I have no doubt that Aurinia will do little with SLE for the foreseeable future . It will be the new owners of Aurina that are better capitalize that will take a peak. Even Glickman said it is not time for SLE.

Remember, end of year readout is just phase 3 trial results. They will need another 9-10 months for approval, so realistically the first revenue won’t be until early 2021. They will definitely have to dilute us shareholders probably after trial results end of this year. So, with VOS, and FGSG costs, it is impossible to do anything significant with SLE. What about funding a salesforce? There is no trial in the works for pediatric SLE either, just an acknowledgement that they may investigate it.